Article
CEMIP as a potential biomarker and therapeutic target for breast cancer patients
1 Jan 2022
Abstract excerpt
We aimed to evaluate whether CEMIP plays any role in the survival outcome of breast cancer (BC) patients, as well as to explore the regulatory mechanism of CEMIP in BC. Methods: We evaluated the expression and prognostic effect of CEMIP in BC patients using the Oncomine, GEPIA, UALCAN, and Kaplan-Meier plotter databases. Additionally, we detected CEMIP mRNA and protein levels in BC and normal tissues via PCR and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
